These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35779608)

  • 1. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
    Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
    Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease.
    Yang X; Chen Z; Luo Z; Yang D; Hao Y; Hu J; Feng J; Zhu Z; Luo Q; Zhang Z; Liang W; Ding G
    Cell Signal; 2023 Sep; 109():110777. PubMed ID: 37329999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
    Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
    Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte as the link between sterile inflammation and diabetic kidney disease.
    Lassén E; Bouchareb R; Daehn IS
    Kidney Int; 2022 Oct; 102(4):688-690. PubMed ID: 36150759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
    Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
    Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
    Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
    Kim D; Ban KY; Lee GH; Jun HS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
    Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
    J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
    Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
    J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice.
    Kunte SC; Marschner JA; Klaus M; Honda T; Li C; Motrapu M; Walz C; Angelotti ML; Antonelli G; Melica ME; De Chiara L; Semeraro R; Nelson PJ; Anders HJ
    Front Immunol; 2023; 14():1230050. PubMed ID: 37744356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.
    Huang D; Kidd JM; Zou Y; Wu X; Gehr TWB; Li PL; Li G
    Inflammation; 2023 Oct; 46(5):2037-2054. PubMed ID: 37477734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.